David Dore is a pharmacoepidemiologist and an AHRQ post-doctoral fellow at the Center for Gerontology and Health Care Research at Brown University.  He received his doctor of pharmacy degree in 2004 from the University of Rhode Island.  While there, Dr. Dore was the recipient of the Rhode Island Pharmacists Association Student Service Award, the American Pharmacists Association Mortar and Pestle Professionalism Award, and the College of Pharmacy Excellence in Research Award.  During his pharmacy training, Dr. Dore focused on pharmacotherapy and he is currently a Ph.D. candidate in epidemiology in the Department of Community Health at Brown.  He serves as a peer-reviewer for a number of journals including Annals of Internal Medicine and Annals of Pharmacotherapy.  Dr. Dore is an active member of the International Society for Pharmacoepidemiology, AcademyHealth, and Kappa Psi Pharmaceutical Fraternity. 

David’s research focuses on the non-experimental study of drug effects, drug safety, and quality in medication use.  He has experience working with clinical-trial data and large databases including Medicaid claims, the Minimum Data Set (MDS), the General Practice Research Database, NHANES and FDA’s Adverse Event Reporting System.  Dr. Dore has research experience in academia and private industry. He remains active in community pharmacy practice and collaborates with physicians, pharmacists, academicians and industry scientists.  He has conducted experimental and non-experimental studies of drug and dietary supplement effects in academia and the pharmaceutical industry.

Publications

Dosa DM, Dore DD, Mor V, Teno JM.  Potentially Inappropriate Initiation of Long-Acting Narcotic Analgesics in Nursing Home Residents.  In Preparation

Dore DD, Lapane KL, Mor V, Trivedi AN, Weinstock M.  Effectiveness of Statins for Prevention of Keratinocyte Carcinomas. In Preparation.

Lapane KL, Quilliam BJ, Dore DD.  Roadblock on the Health IT Superhighway: E-prescribing and the Controlled Substances Act. Submitted.

Dore DD, Lapane KL. Prevalence and Correlates of Stimulant Medication Use in U.S. Adults: 1999-2002. Submitted.

Dore DD, DiBello JR, Lapane KL. Telithromycin Use and Spontaneous Reports of Hepatotoxicity. Submitted.

Dore DD, Zierler S. Over-Reliance on Patient Information Sheets (letter). American Journal of Medicine, In Press.

Caron MF, Dore DD, Min B, Kluger J, Boguk I, White CM. The Electrocardiographic and Blood Pressure Effects of the Ephedra Containing TrimSpa Thermogenic Herbal Compound in Healthy Volunteers. Pharmacotherapy, In Press.

Dore DD, Larrat EP, Vogenberg FR, Principles of Epidemiology for Clinical and Formulary Management Professionals (CME). P&T 2006; 31(4): 218-229.

Dore DD, DiBello JR, Lapane KL. Evaluating telithromycin-related hepatotoxicity: an application of the case-control design to spontaneous report data. (Abstract) Pharmacoepidemiology and Drug Safety, In Press.

Dore DD, Mor V. Prevalence and Determinants of Atypical Antipsychotic use in Nursing Home Residents with Parkinson's Disease. In Preparation.

Dore DD, Bunz TJ, Kogut SJ. Drug therapy for Alzheimer's disease: Persistence on cholinesterase inhibitors measured using Medicaid pharmacy claims data. (Presentation Abstract). J Am Pharm Assoc (Wash DC). 2004 Mar-Apr;44(2):229.

Bunz TJ, Dore DD, Kogut SJ. Persistence after cholinesterase therapy
change in a Medicaid dataset. (Poster Abstract) J Am Pharm Assoc (Wash DC). 2004 Mar-Apr;44(2):229.